All In Biotech

Drug Trial Radar · NCT05635227

Dexamethasone, Olanzapine, Hemodynamics, and Ventilation in Cardiac Surgery

Dexamethasone, Olanzapine, Flow-targeted Versus Pressure-targeted Hemodynamic Management, and Low Tidal Volume Ventilation in Patients Undergoing On-pump Cardiac Surgery - a Multifactorial Design Randomized Trial

Last checked: Nov 19, 2026Latest source record: Apr 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 1,200 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,200

Planned (sponsor's estimate)

Start

Nov 10, 2022

Primary completion

Dec 2027

Study completion Feb 2028

Sponsor

Lead sponsor
Copenhagen University Hospital, RigshospitaletAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 2, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Factorial
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Open heart surgery, including coronary artery bypass grafting (CABG) and/or aortic valve replacement (AVR) is associated with a significant risk of mortality. This study is a randomized clinical trial with the purpose of investigating four different interventions on the primary endpoint 'days alive and outside of hospital within 90 days'. The interventions are: * Dexamethasone vs. placebo administered after induction of anesthesia. * Olanzapine vs. placebo administered prior to anesthesia. * A blood-flow targeted vs. a blod-pressure targeted hemodynamic strategy while the patient is on cardio-pulmonary bypass (CPB) * Low-tidal volume ventilation vs. no ventilation of the lungs while the patient is on CPB

Conditions

  • Coronary Artery Disease
  • Aortic Valve Disease

Interventions

  • Dexamethasone phosphateDrug

    See description of arms

  • Isotonic sodium chloride (0.9%)Drug

    See description of arms

  • Olanzapine 10 MGDrug

    Olanzapine tablet pre-hidden in capsule identical to the placebo tablet

  • Placebo capsuleDrug

    capsule identical to capsule containing olanzapine

  • Flow-targeted hemodynamic managementProcedure

    See description of arms

  • Pressure-targeted hemodynamic managementProcedure

    See description of arms

  • Low tidal-volume ventilationProcedure

    See description of arms

  • No ventilationProcedure

    See description of arms

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Days alive and outside hospitalTime frame: 90 days from surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Heart Centre, Rigshospitalet

    Copenhagen, Denmark · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.